Farnesyltransferase Inhibitors in Cancer Therapy - Couverture rigide

Couverture rigide

ISBN 10 : 0896036294 ISBN 13 : 9780896036291

Editeur : Humana Press Inc., 2000

Synopsis

Cutting-edge researchers describe their efforts to design, synthesize, and evaluate the biological activities of farensyltransferase inhibitors (FTIs); geranylgeranyltransferase inhibitors (GGTIs) are also discussed as potential anticancer drugs. The authors survey in detail such inhibitors as CAAX box peptidomimetics, FPP mimics, and bisubstrate transition state analogs, and critically review their uses in combination with radiation and other cytotoxic agents, such as gemcitabine, cisplatin, and taxanes. Illuminating and richly detailed, Farnesyltransferase Inhibitors in Cancer Therapy constitutes today's standard reference for the pathbreaking use of FTIs and GGTIs in anticancer therapy and offers basic and clinical investigators a comprehensive treatment of the scientific and medical aspects of farnesyltransferase inhibitors.

Détails de l'édition

• Éditeur: Humana Press Inc.
• Date d'édition: 2000
• Langue: anglais
• ISBN 10: 0896036294
• ISBN 13: 9780896036291
• Reliure: Relié
• Nombre de pages: 292
• Éditeur: Sebti Saïd M., Hamilton Andrew D.
• Coordonnées du fabricant: ProductSafety@springernature.com; ProductSafety@springernature.com; ; Poststr. 9; Darmstadt; 64293; Allemagne